Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA minor version update occurred from v3.3.1 to v3.3.2 with no changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedA note was added clarifying that Publications are automatically filled from PubMed, and the page revision indicator was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check32 days agoChange DetectedRemoval of the government funding status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedThe new screenshot shows a rearranged but substantively identical ClinicalTrials.gov Study Details page with all sections present and no new content added or removed. Minor layout adjustments observed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check76 days agoChange DetectedUpdated the page to show revision v3.2.0 and removed v3.0.2.SummaryDifference0.1%

- Check77 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content or pricing/availability changes detected.SummaryDifference0.1%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.